SI1905773T1 - Compounds and methods for inhibiting mitotic progression by inhibition of aurora kinase - Google Patents

Compounds and methods for inhibiting mitotic progression by inhibition of aurora kinase

Info

Publication number
SI1905773T1
SI1905773T1 SI200531593T SI200531593T SI1905773T1 SI 1905773 T1 SI1905773 T1 SI 1905773T1 SI 200531593 T SI200531593 T SI 200531593T SI 200531593 T SI200531593 T SI 200531593T SI 1905773 T1 SI1905773 T1 SI 1905773T1
Authority
SI
Slovenia
Prior art keywords
inhibition
compounds
methods
aurora kinase
mitotic progression
Prior art date
Application number
SI200531593T
Other languages
Slovenian (sl)
Inventor
Christopher F. Claiborne
Lloyd J. Payne
Richard J. Boyce
Todd B. Sells
Stephen G. Stroud
Stuart Travers
Tricia J. Vos
Gabriel S. Weatherhead
Original Assignee
Millennium Pharmaceuticals, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Millennium Pharmaceuticals, Inc. filed Critical Millennium Pharmaceuticals, Inc.
Priority claimed from EP07024446A external-priority patent/EP1905773B1/en
Publication of SI1905773T1 publication Critical patent/SI1905773T1/en

Links

SI200531593T 2004-05-14 2005-05-12 Compounds and methods for inhibiting mitotic progression by inhibition of aurora kinase SI1905773T1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US57165304P 2004-05-14 2004-05-14
US61722104P 2004-10-08 2004-10-08
EP07024446A EP1905773B1 (en) 2004-05-14 2005-05-12 Compounds and methods for inhibiting mitotic progression by inhibition of aurora kinase

Publications (1)

Publication Number Publication Date
SI1905773T1 true SI1905773T1 (en) 2013-01-31

Family

ID=38701499

Family Applications (1)

Application Number Title Priority Date Filing Date
SI200531593T SI1905773T1 (en) 2004-05-14 2005-05-12 Compounds and methods for inhibiting mitotic progression by inhibition of aurora kinase

Country Status (3)

Country Link
CN (1) CN101014603B (en)
SI (1) SI1905773T1 (en)
ZA (1) ZA200609913B (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0803747D0 (en) * 2008-02-29 2008-04-09 Martin Enzyme and receptor modulation
JP2013520424A (en) * 2010-02-19 2013-06-06 ミレニアム ファーマシューティカルズ， インコーポレイテッド Sodium 4-{[9-chloro-7- (2-fluoro-6-methoxyphenyl) -5H-pyrimido [5,4-d] [2] benzoazepin-2-yl] amino} -2-methoxybenzoate Crystal form
UY34114A (en) * 2011-06-03 2013-01-03 Millennium Pharm Inc COMBINATION OF MEK INHIBITORS AND SELECTIVE INHIBITORS OF QUIINASA AURORA A
CN103724351A (en) * 2012-10-11 2014-04-16 韩冰 Compound for treating cerebral palsy and use thereof
CN103408551B (en) * 2013-07-25 2015-08-05 苏州明锐医药科技有限公司 The preparation method that A Lisai replaces

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2001507349A (en) * 1996-12-23 2001-06-05 セルテック セラピューティックス リミテッド Fused polycyclic 2-aminopyrimidine derivatives, their preparation and their use as protein tyrosine kinase inhibitors

Also Published As

Publication number Publication date
CN101014603A (en) 2007-08-08
ZA200609913B (en) 2007-12-27
CN101014603B (en) 2014-08-20

Similar Documents

Publication Publication Date Title
HK1205102A1 (en) Compounds and methods for inhibiting mitotic progression by inhibition of aurora kinase
ME00716B (en) Compounds and methods for inhibiting mitotic progression by inhibition of aurora kinase
EP1957078A4 (en) Pyrrolotriazine derivatives useful for treating cancer through inhibition of aurora kinase
HK1096972A1 (en) Inhibition of syk kinase expression
GB2432165B (en) Method of inhibiting hydrate formation
IL189933A0 (en) Rna antagonist compounds for the inhibition of apo-b100 expression
EP2121637A4 (en) Anthranilamide inhibitors of aurora kinase
ZA200804253B (en) Method of inhibiting FLT3 kinase
IL198690A0 (en) Compounds for inhibiting mitotic progression
ZA200704106B (en) Inhibitors of c-fms kinase
EP1954290A4 (en) Tricyclic compounds useful as inhibitors of kinases
IL172375A0 (en) Chinazoline derivatives as aurora kinase inhibitors
EP1778693A4 (en) Tricyclic-heteroaryl compounds useful as kinase inhibitors
HK1144392A1 (en) Pyrrolotriazine derivatives useful for treating cancer through inhibition of aurora kinase
GB0608823D0 (en) Inhibitors of P13 kinase
ZA200809874B (en) Method of inhibiting c kit kinase
IL182735A0 (en) Inhibitors of c-fms kinase
EP1906967A4 (en) Abl kinase inhibition
SI1905773T1 (en) Compounds and methods for inhibiting mitotic progression by inhibition of aurora kinase
EP1771203A4 (en) Inhibition of nf-kb
EP1605893A4 (en) Trans-membrane-antibody induced inhibition of apoptosis
PL1905773T3 (en) Compounds and methods for inhibiting mitotic progression by inhibition of aurora kinase
EP1776140A4 (en) Methods of inhibiting viral replication
GB0410299D0 (en) Inhibition of biofilm formation
GB0621606D0 (en) Inhibitors of p13 kinase